High intralesional interleukin-10 messenger RNA expression in localized cutaneous leishmaniasis is associated with unresponsiveness to treatment

Journal of Infectious Diseases

Volumn 184, Issue 12, 2001, Pages 1628-1630

  Bourreau, E ^a   Preevot G ^a   Gardon, J ^a   Pradinaud, R ^b   Launois, P ^a  

^a INSTITUT PASTEUR DE LA GUYANE   (French Guiana)

^b Centre Hospitalier Général A Rosemon   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; INTERLEUKIN 10; MESSENGER RNA; PENTAMIDINE ISETHIONATE;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHILD; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DRUG RESPONSE; FEMALE; HUMAN; LEISHMANIA; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REMISSION; SENSITIVITY AND SPECIFICITY; SKIN LEISHMANIASIS; TREATMENT FAILURE;

ADOLESCENT; ADULT; ANIMALS; ANTIPROTOZOAL AGENTS; CHILD; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-10; LEISHMANIA GUYANENSIS; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED; PENTAMIDINE; RNA, MESSENGER; TREATMENT FAILURE;

EID: 0035893060     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/324665     Document Type: Article

References (13)

1. Cytokine patterns in the pathogenesis of human leishmaniasis
2. Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction
3. In situ expression of interleukin-10 and interleukin-12 in active human cutaneous leishmaniasis
4. + T cells unresponsive to IL-12
5. Interleukin-10 production correlates with pathology in human Leishmania donovani infections
6. High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis
7. Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major
8. Interleukin-12 regulates the response to chemotherapy in experimental visceral leishmaniasis
9. Treatment of experimental visceral leishmaniasis in a T-cell deficient host: Response to amphotericin B and pentamidine
10. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
11. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression
12. Interleukin-10 down-regulates MHC class II αβ peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling
13. Dendritic cells and the control of immunity